Cashu Finance
  • Terminal
  • Stocks
  • Spotlight
  • Research
Log inSign Up
  1. Stocks
  2. Healthcare
  3. NASDAQ
  4. IMMP

Market Cap: $55.01M

IL

Immutep Limited

IMMP
NASDAQUSD
Purchase IMMP
OverviewNewsAnalyst ReportsFinancialsPolitician TradesInsider TradesExecutivePatentsEarnings Surprise
Cashu Finance

By Cashu Finance. Providing market news, analysis, and research for investors worldwide.

Company

StocksAboutAdvertisersBrokersContact

Legal

Terms of ServicePrivacy Policy

© 2026 Cashu Technologies Pty Ltd. All rights reserved. Cashu Finance is a trademark of Cashu Technologies Pty Ltd.

The content published on Cashu Finance is for informational purposes only and should not be construed as investment advice, a recommendation, or an offer to buy or sell any securities. All opinions expressed are those of the authors and do not reflect the official position of Cashu Technologies Pty Ltd or its affiliates. Past performance is not indicative of future results. Investing involves risk, including the possible loss of principal. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions.

Cashu Finance and its contributors may hold positions in securities mentioned in published content. Any such holdings will be disclosed at the time of publication. Market data is provided on an "as-is" basis and may be delayed. Cashu Technologies Pty Ltd does not guarantee the accuracy, completeness, or timeliness of any information presented.

Financials

Profitability
Gross Profit Margin84.97%
EBITDA Margin-5.82%
EBIT Margin-5.97%
Pre-tax Margin-5.45%
Net Profit Margin-5.45%
Earnings Yield-96.09%
Valuation Multiples
Price / Book1.34
Price / Sales5.67
Price / Earnings-1.04
PEG0.03
Forward PEG-0.07
EV / Sales1.01
EV / EBITDA-0.17
EV / Operating Cash Flow-0.27
EV / Free Cash Flow-0.26
Price / Free Cash Flow-1.49
Price / Operating Cash Flow-1.49
Cash Flow & Capital
Free Cash Flow / Share-$0.38
Operating Cash Flow / Share-$0.38
Free Cash Flow Yield-67.32%
Capex / Revenue0.64%
Capex / Operating Cash Flow-0.17%
Capex / Depreciation0.04
Stock Compensation / Revenue0.00%
Dividend Payout Ratio0.00%
Dividend Yield0.00%
Liquidity & Leverage
Current Ratio5.69
Quick Ratio5.69
Cash Ratio4.86
Debt / Assets0.01
Debt / Capital0.02
Debt / Equity0.02
Long-Term Debt / Capital0.00
Debt / Market Cap0.35%
Net Debt / EBITDA0.80
Solvency Ratio-3.55
Financial Leverage1.35
Efficiency & Working Capital
Asset Turnover0.17
Fixed Asset Turnover13.27
Inventory Turnover0.00
Receivables Turnover1.51
Payables Turnover0.37
Days Sales Outstanding241.3
Days Inventory Outstanding0
Days Payables Outstanding981.96
Operating Cycle241.3
Cash Conversion Cycle-740.67
Working Capital Turnover0.18
Returns & Quality
Return on Equity-98.86%
Return on Assets-95.24%
Return on Invested Capital-1.25%
ROCE-1.26%
Return on Tangible Assets-96.98%
Operating Return on Assets-75.47%
Income Quality0.70
Tax Burden1.00
Interest Burden0.91
Balance Sheet & Intrinsic Metrics
Enterprise Value$14.7M
Invested Capital$69.06M
Working Capital$66.47M
Tangible Asset Value$60.04M
Net Current Asset Value$58.89M
Graham Net-Net$0.37
Book Value / Share$0.42
Tangible Book Value / Share$0.41
Cash / Share$0.47
Financial Health Scores
Piotroski Score4
Altman Z-Score-11.62
Revenue$21.69M
EBIT$-150.58M
Market Cap$68.17M
Working Capital$66.47M
Retained Earnings$-520.83M
Total Assets$83.27M
Total Liabilities$21.74M